Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519018) titled 'TIS for Drug Resistant TLE' on April 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Xijing Hospital

Condition: Epilepsy

Intervention: Device: TI Stimulation

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 15, 2026

Target Sample Size: 30

To know more, visit https://clinicaltrials.gov/study/NCT07519018

Published by HT Digital Content Services with permission from Health Daily Digest....